معرفی
Sunghee Cho, Ph.D., is a Professor of Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medicine, and Director of the Stroke Neuroimmunology Laboratory at Burke Neurological Institute. Her research focuses on neuron-immune interactions in stroke-induced brain injury and repair mechanisms. She holds affiliations with Burke Medical Research Institute and serves on editorial boards for Stroke, Cerebral Blood Flow/Metabolism, and Translational Stroke Research. Dr. Cho is a Fellow of the American Heart/Stroke Association and a chartered member of the NIH Neural Oxidative Metabolism and Death (NOMD) study section. Her work is funded by NIH grants (NINDS, NHLBI, NCRR), the American Heart Association, and industry partnerships like Sanofi.
Education
- B.S., Chemistry, Yonsei University (Korea)
- M.S., Human Nutrition, Cornell University
- Ph.D., Neuroscience, Weill Cornell Medical College
- Postdoctoral Fellowship at Weill Cornell Medical College (Molecular Neurobiology)
Research Interests
Dr. Cho’s lab investigates immune mechanisms in stroke, particularly CD36’s role in BBB dysfunction, monocyte infiltration, and neuroinflammation. Key areas include stroke recovery modulation via CD36 inhibition, obesity-stroke comorbidities, and translational therapies targeting neurovascular interactions. Her studies bridge preclinical models and clinical relevance, emphasizing stroke recovery and resilience in neurodegenerative conditions.
Publications & Awards
Recent work includes breakthroughs in CD36-mediated efferocytosis and stroke recovery (2025), 2-deoxyglucose-driven neuroplasticity (2023), and VEGF-trap therapies (2021). Awards include FAHA Fellowship and NIH leadership roles in international consortia.
Labs & Collaborations
Primary lab: Cho Lab. Collaborations with Gibson Lab, Ratan Lab, and the NINDS European consortium. Research methods include gene expression analysis, molecular studies, and neuroimmunology techniques.
